CD4/CD8 Ratio During Human Immunodeficiency Virus Treatment: Time for Routine Monitoring?
Raquel Ron, Sergio Serrano‐Villar, Elena Moreno(Instituto de Salud Carlos III), Talía Sainz(Hospital Universitario La Paz), Santiago Moreno(Hospital Universitario Ramón y Cajal), Javier Martínez‐Sanz(Instituto Cajal), Fátima Brañas(Hospital Universitario Infanta Leonor)
Cited by 72
Related Papers
Care of patients with chronic hepatitis C and HIV co-infection: recommendations from the HIV–HCV International Panel
|AIDS|2002|443
Description of COVID-19 in HIV-infected individuals: a single-centre, prospective cohort
|The Lancet HIV|2020|396
Less Lipoatrophy and Better Lipid Profile With Abacavir as Compared to Stavudine
|JAIDS Journal of Acquired Immune Deficiency Syndromes|2006|137
A Randomized Clinical Trial Comparing Nelfinavir Or Nevirapine Associated to Zidovudine/Lamivudine in HIV-Infected Naive Patients (The Combine Study)
|Antiviral Therapy|2002|137
Effects of tocilizumab on mortality in hospitalized patients with COVID-19: a multicentre cohort study
|Clinical Microbiology and Infection|2020|108